Table 2: Comparison of Potency (µM, IC50) of Commercial Ordered Compounds in ELISA-Based TNF-α, HTRF-Based TNF-α, and Cell Viability Assays

Compound Name ELISA HTRF Cytotoxicity
Bay 11-7085 0.33 ± 0.15 1.45 ± 0.11 7.72
BTO-1 1.95 ± 0.7 4.61 ± 0.37 12.9
CCG-2046 0.64 ± 0.09 2.44 ± 0.002 8.66
Dobutamine hydrochloride 0.09 ± 0.05 0.21 ± 0.02 Inactive
Ellipticine 0.44 ± 0.07 1.38 ± 0.22 10.9
Histamine dihydrochloride 0.71 ± 0.31 1.37 ± 0.003 Inactive
IRAK-1/4 Inhibitor I 0.54 ± 0.1 3.14 ± 1.69 Inactive
PD 169316 0.01 ± 0.001 0.07 ± 0.01 25.9

Each value in ELISA and HTRF-based assays is the mean ± SD of the results from two experiments in duplicates. Cell viability assay was performed in duplicates from one experiment.